In this Issue
Counseling patients on how these alterations may affect glaucomatous disease.
By Robert J. Noecker, MD
Nonpenetrating surgery and novel, investigational, Schlemm’s canal shunting devices reduce dependence on the healing whims of the conjunctiva.
By Thomas W. Samuelson, MD
Debunking the dogma underlying the monocular drug trial.
By Tony Realini, MD
Ocular hypertension affects the blue/yellow neurons.
By Yeni H. Yücel, MD, PhD; Robert N. Weinreb, MD; Paul L. Kaufman, MD; and Neeru Gupta, MD, PhD
By Lisa A. Herrygers, MD
By David L. Epstein, MD
Assistance in selecting a unit.
By Leon W. Herndon, MD
A complication of drainage device surgery.